2024-09-20 - Analysis Report
## Johnson & Johnson (JNJ) Stock Analysis

**Company Overview:** Johnson & Johnson is a multinational healthcare conglomerate that develops, manufactures, and sells a wide range of medical devices, pharmaceutical products, and consumer healthcare goods.

**Performance Analysis:**

**1. Performance vs. S&P 500 (VOO):**

* **Cumulative Return:** JNJ (38.86%) significantly lags behind the S&P 500 (128.99%).
* **Relative Divergence:** Currently, JNJ is underperforming the S&P 500 by -90.13%, placing it at the 13.01% percentile of historical performance.

**2. Recent Price Action:**

* **Closing Price:** $166.18
* **Moving Averages:**
    * 5-day: $166.01
    * 20-day: $165.11
    * 60-day: $158.04

This indicates a recent upward trend with the price above all moving averages.

**3. Technical Indicators:**

* **RSI:** 57.38 - Suggesting a neutral to slightly bullish sentiment.
* **PPO:** -0.15 - Indicating a possible minor downtrend.
* **Delta_Previous_Relative_Divergence:** 3.64 - Suggests a potential short-term upward trend.
* **Expected Return:** 12.75% - Represents the potential 5-year return on a current investment, providing a long-term outlook.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-25 | 1.95 | $22.45 B |
| 2024-05-01 | 1.35 | $21.38 B |
| 2024-02-16 | 1.68 | $21.39 B |
| 2023-10-27 | 10.32 | $21.35 B |
| 2024-02-16 | 10.32 | $21.35 B |

* **Latest Earnings:** 1.95 EPS and $22.45B revenue for the quarter ended 2024-07-25. 
* **Outlook:** While recent earnings are positive, JNJ faces challenges in its pharmaceutical and medical device segments due to increasing competition.

**Overall Analysis:**

JNJ has underperformed the S&P 500 over the long term, with a significant negative divergence. However, the stock has shown some positive signs recently, with an upward price trend and positive technical indicators. The recent earnings were better than expected, but the company faces challenges in the future. 

**Investment Conclusion:**

Investors should consider JNJ's long-term underperformance and current market dynamics before making any investment decisions. The potential for growth is present but needs to be weighed against the risks associated with the healthcare industry. It is important to conduct thorough research and seek professional financial advice before making any investment decisions.
